Medical Weight Loss in Spokane & Liberty Lake — Lose 15–25% of Your Body Weight

GLP-1 medications mimic a natural hormone that regulates appetite and blood sugar. They slow gastric emptying, reduce hunger signals to the brain, and help you feel full longer. Tirzepatide also targets the GIP receptor, adding a second mechanism that improves insulin sensitivity. Result: significant calorie reduction without constant willpower battles.

Semaglutide targets the GLP-1 receptor and produces 15–17% body weight loss on average over 68 weeks of treatment (STEP trials). Tirzepatide targets BOTH GLP-1 and GIP receptors, producing 20–22% average body weight loss (SURMOUNT trials) — and provides stronger insulin sensitivity benefit. Dr. Belkoff helps each patient choose the right option based on labs, goals, and history.

Semaglutide programs start at $175/month and tirzepatide programs at $250/month. Both include the medication, comprehensive lab work at baseline, body composition analysis, unlimited messaging and telehealth visits, and unlimited in-office check-ins with Dr. Belkoff. No hidden fees, no contracts, no enrollment charges.

Clinical studies show average weight loss of 15–17% with semaglutide and 20–22% (sometimes more) with tirzepatide over 12–18 months. Individual results depend on starting weight, adherence, dose titration, and lifestyle factors. Most patients also see improvements in energy, sleep, blood pressure, cholesterol, and joint pain.

GLP-1 medications have extensive clinical trial data supporting their safety and effectiveness when used under physician supervision. The most common side effect is mild nausea during initial dose titration, which typically resolves within 2–4 weeks. Dr. Belkoff monitors every patient with regular lab work and adjusts dosing to minimize side effects.

Your first visit is a one-on-one consultation directly with Dr. Belkoff, DO. He reviews your full medical history, current medications, and weight loss goals; orders a comprehensive metabolic blood panel; performs a body composition analysis; and outlines your personalized treatment plan. The consultation itself is free with no commitment to start treatment.

GLP-1 medications work powerfully on their own, but combining them with sensible nutrition and regular movement significantly improves results and helps maintain weight loss long-term. Dr. Belkoff provides personalized nutrition guidance — no extreme dieting, just sustainable habits that work alongside your medication.

Yes we offer telehealth visits as well, but we are highly flexible. For example, after your initial consultation whether it be in person or via telehealth you can choose in person or telehealth visits going forward. This is convenient for patients across Spokane, Spokane Valley, Liberty Lake, Post Falls, Coeur d'Alene, and the broader Inland Northwest. We're licensed in 8 states and can serve patients throughout Washington and Idaho via telehealth.

Most patients see optimal results over 6–12 months. Once you reach your target weight, Dr. Belkoff develops a personalized maintenance plan — which may include tapering medication, transitioning to a lower maintenance dose, or focusing on lifestyle and metabolic health to maintain results long-term. The plan is designed around your individual response and goals, not a template.

Ozempic and Wegovy are brand-name semaglutide manufactured by Novo Nordisk. Compounded semaglutide is the same active ingredient prepared by a licensed 503A pharmacy under physician prescription. Compounded versions are typically more affordable and accessible during brand shortages. Dr. Belkoff prescribes compounded semaglutide as our primary offering and brand-name Ozempic, Wegovy, Mounjaro, or Zepbound on patient request.

Most insurance plans do not cover GLP-1 medications for weight loss without a type 2 diabetes diagnosis, and even then coverage varies. That's why our membership is flat-rate cash pricing — no insurance hoops, no surprise bills, no prior authorizations. Patients with HSA/FSA accounts can typically use those funds.

Most side effects are mild and dose-dependent: nausea, fatigue, constipation, and mild GI upset, especially during dose increases. They typically resolve within days as your body adapts. Serious side effects are rare. Because we titrate slowly under physician supervision and adjust dosing based on tolerance, most patients experience minimal issues. Patients with personal/family history of medullary thyroid carcinoma or MEN2 syndrome are not candidates.

Many patients report decreased alcohol cravings and tolerance on GLP-1 medications — this is one of the most-discussed effects. Moderate alcohol is generally okay, but it can worsen nausea, slow weight loss, and stress the liver. We recommend patients minimize or eliminate alcohol during the active weight loss phase for best results.

Prime Body Solutions is located in Liberty Lake, WA — a 15-minute drive from downtown Spokane and just across the state line from Post Falls and Coeur d'Alene, ID. We serve patients throughout the Inland Northwest with both in-person and telehealth options. Dr. Cody Belkoff, DO is the supervising physician for every patient.

Studies show patients who stop GLP-1 therapy abruptly without lifestyle changes regain a portion of weight. That's why our program emphasizes nutrition, strength training, and metabolic optimization alongside medication — so when you taper or stop, your habits and metabolism support the result. Some patients transition to a low maintenance dose or microdosing protocol with Dr. Belkoff.